This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Ross Kenneth Urken

Ross Kenneth Urken is editor of MainStreet and personal finance editor at TheStreet. He has published in The New York Times, The Wall Street Journal, New York Magazine, Tablet, Slate, TENNIS Magazine, The Paris Review, and Forbes. He is a former editor at AOL and focuses on personal finance, cars, digital wallet technology, investing, and life-stage planning. He has also extensively covered culture, nightlife, and the automotive industry and hosts several on-camera webisodes. He is a graduate of Princeton University, where he studied comparative literature.

Ross Kenneth Urken
By This Author:
« Back
Page 1 of 9

Rooster Infertility Drives Up Price of Chicken: Crisis at the Coop

By Ross Kenneth Urken

Aviagen Group, the largest producer of breeding chickens, has found that tweaking the genes of its mainstay rooster has rendered the crowing male chickens less fertile.

01:11PM 07/10/14

Obama's Student Loan Forgiveness Plan Finds Amped Up Volume

By Ross Kenneth Urken

President Obama wants to make good on his promise to stanch the student loan debt hemorrhage.

03:22PM 06/09/14

Growing Hemp in the Bluegrass State to Treat PTSD

By Ross Kenneth Urken

Industrial hemp advocacy and the therapeutic bent to agriculture both come to a head in Healing Grounds, an organization started this year by Fred-Curtis Lewis, a 36-year-old vet in Kentucky.

05:34PM 05/29/14

Can Growing Hemp Cure PTSD in Iraq and Afghanistan War Vets?

By Ross Kenneth Urken

Industrial hemp advocacy and the therapeutic bent to agriculture both come to a head in Healing Grounds, an organization started this year by Fred-Curtis Lewis.

02:13PM 05/29/14

Cannabis Legalization From Bloodshed to Regrowth

By Ross Kenneth Urken

Jacob Shepherd, whose father was shot dead 20 years ago for growing marijuana, has - along with Mary Jane Jones, his mother - used this low point as an impetus to fight for cannabis legalization in Kentucky and beyond.

09:43AM 05/29/14

Cannabis Legalization Evangelists Found Purpose In Difficult Loss

By Ross Kenneth Urken

Mary Jane Jones, 62, and her son Jacob Shepherd, 24, have become cannabis evangelists since the herb led their family to tragedy 20 years ago.

11:58AM 05/28/14

Hemp in Kentucky Creates Latest Drug War Battleground

By Ross Kenneth Urken

Two military veteran brothers in Kentucky are fighting a battle to grow industrial hemp in the soil they served their country to defend. But they face an enemy they're not trained to fight in bringing grass to the Bluegrass State.

03:23PM 05/27/14

Growing Warriors Set to Bring Industrial Hemp to Kentucky

By Ross Kenneth Urken

Two military veteran brothers in Kentucky are fighting a battle to grow industrial hemp in the soil they served their country to defend, but they're up against the DEA.

12:43PM 05/27/14

Porsche Sued Over Paul Walker Death: A Fast and Furious Legal Matter

By Ross Kenneth Urken

Porsche is facing a lawsuit from Kristine Rodas, the widow of Roger Rodas, who was driving the Carrera GT that crashed last November, killing him and passenger Paul Walker.

02:58PM 05/13/14

Morgan Stanley Cozies Up to Medical Marijuana Stock GWPH

By Ross Kenneth Urken

Morgan Stanley has given GW Pharmaceuticals its vote of confidence with a bullish "overweight" rating and a $103 price target on account of the upside potential of epilepsy drug Epidiolex.

10:45AM 04/23/14

« Back
Page 1 of 9

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs